Novavax shares are trading higher after the company announced an amendment to its Canada supply agreement, under which Canada will pay the company $349.6 million for forfeiting certain doses of its COVID vaccine.
Portfolio Pulse from Benzinga Newsdesk
Novavax has amended its supply agreement with Canada, resulting in Canada paying the company $349.6 million for forfeiting certain doses of its COVID vaccine. This has led to a rise in Novavax's share price.
July 10, 2023 | 3:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax's stock price is trading higher following the amendment to its supply agreement with Canada, which will see the company receive $349.6 million for forfeiting certain doses of its COVID vaccine.
The news directly impacts Novavax as it is about an amendment to its supply agreement with Canada. This amendment results in a significant payment to Novavax, which is positive news for the company and its shareholders, leading to a rise in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100